Product Profile: Pregaloop (Progesterone Injection IP 100mg/ml) Pregaloop injection contains natural Progesterone in an oil-based vehicle, formulated for intramuscular administration. This preparation is used when oral progesterone is not indicated or when higher bioavailability is required for rapid therapeutic response in reproductive medicine and gynecological care. 1. Clinical Indications & Usage Luteal Phase Support: A standard therapy in Assisted Reproductive Technology (ART) protocols (e.g., IVF) to ensure adequate progesterone levels for implantation and maintenance of early pregnancy. Amenorrhea: Treatment of secondary amenorrhea (the absence of menstrual periods) in non-pregnant, non-nursing women. Abnormal Uterine Bleeding: Used in the management of dysfunctional uterine bleeding due to hormonal imbalance. 2. Mechanism of Action Endometrial Transformation: Progesterone acts on an estrogen-primed endometrium, converting it from a proliferative to a secretory state. This is essential for rendering the uterus receptive to embryo implantation and supporting placental development. Hormonal Feedback: It suppresses the production of gonadotropins (FSH and LH) by the pituitary gland and helps normalize the menstrual cycle. Direct Bioavailability: By bypassing the first-pass metabolism in the liver (which occurs with oral dosing), the injectable form provides direct, reliable systemic availability of the hormone. 3. Administration and Dosing Route: Must be administered by deep intramuscular (IM) injection, typically into the upper outer quadrant of the gluteus muscle. Professional Requirement: This is a professional-grade injectable. Administration must be performed by a qualified healthcare provider under aseptic conditions. Preparation: The oil-based solution should be warmed slightly by rolling the vial between the palms if the medication has thickened, and checked for particulate matter prior to injection. ⚠️ Safety, Side Effects, and Monitoring Contraindications: Do not use if the patient has undiagnosed vaginal bleeding, known hypersensitivity to progesterone, severe liver disease, known or suspected breast or genital cancer, or history of thromboembolic disorders (e.g., DVT, pulmonary embolism). Common Side Effects: Injection site reactions (pain, redness, or swelling), breast tenderness, nausea, fatigue, dizziness, and mood changes. Monitoring: Patients should be monitored for signs of fluid retention, which may exacerbate conditions such as asthma, epilepsy, or migraine. 📦 Storage, Stability & Commercial Packaging Storage: Store at controlled room temperature (20°C to 25°C / 68°F to 77°F). Protection: Keep in original packaging to protect from light. Do not refrigerate or freeze. Security: Keep strictly out of reach of children. PRESCRIPTION MEDICINE IS: YES. Disclaimer: This profile is compiled strictly for international wholesale procurement and commercial educational research. Pregaloop Injection is a prescription medicine and must be utilized solely under the direct guidance of a licensed reproductive endocrinologist or physician. All cross-border importing setups must comply with the native health authorities of the destination country. 📞 Contact Ernest Impex — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Official Websites: www.ernestimpex.com www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com 📧 Corporate Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 📲 WhatsApp Link: https://wa.me/919359902383